Fatty acids and the immune system: from basic science to clinical applications
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Over the last 25 years, the effects of fatty acids on the immune system have been characterized using in vitro, animal and human studies. Advances in fatty acid biochemistry and molecular techniques have recently suggested new mechanisms by which fatty acids could potentially modify immune responses, including modification of the organization of cellular lipids and interaction with nuclear receptors. Possibilities for the clinical applications of n-3 PUFA are now developing. The present review focuses on the hypothesis that the anti-inflammatory properties of n-3 PUFA in the arterial wall may contribute to the protective effects of n-3 PUFA in CVD, as suggested by epidemiological and secondary prevention studies. Studies are just beginning to show that dietary n-3 PUFA can be incorporated into plaque lipid in human subjects, where they may influence the morphology and stability of the atherosclerotic lesion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 8×
“Several studies have shown no effect on levels of soluble VCAM-1, while one study reported an increase (Johansen et al. 1999) and one study reported that supplementation with a moderate dose of fish oil (1.2 g EPA + DHA/d) for 12 weeks decreased plasma levels of soluble VCAM-1 in older subjects, but did not have any e…”
BackgroundInfluentialThe Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177 · cited 1×
“…that consumption of fish or long-chain n-3 PUFA found in oily fish and fish oils protects against CVD inWestern populations (Miettinen et al. 1982; Kromhout et al. 1985, 1995; Shekelle et al. 1985; Norell et al. 1986; Feskens et al. 1993; Siscovick et al. 1995; Daviglus et al. 1997; Albert et al.…”
BackgroundKliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164 · cited 1×
“…to be no distinction between the n-3 PUFA and the n-6 PUFA in their binding affinity and/ or activating capacity, and no relationship with chain length or number of double bonds (Forman et al. 1997; Kliewer et al. 1997; Krey et al. 1997; Lin et al. 1999; Wolfrum et al. 2001; Xu et al. 2001).”
BackgroundForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692 · cited 1×
“…that the plasma level of CRP is a strong independent predictor of future myocardial infarction, stroke and pulmonary vascular disease among individuals without known CVD (Kuller et al. 1996; Tracy et al. 1997; Ridker et al. 1998, 2000; Koenig et al. 1999; Danesh et al. 2000; Mendall et al. 2000).”
BackgroundThe PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · cited 1×
“…and PPAR-a ligands have been demonstrated to inhibit phorbol esterstimulated cytokine production by monocytic cells (Jiang et al. 1998) and studies using PPAR-a knock-out mice have demonstrated prolonged inflammatory responses (Devchand et al. 1996), suggesting that PPAR may be anti-inflammatory.”
BackgroundLee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311 · cited 2×
“…who had already suffered a myocardial infarction, demonstrate substantial benefit (for example, see Burr et al. 1989; Singh et al. 1997; GISSI Prevenzione, 1999; Marchioli et al. 2002), although one study demonstrated a higher risk of cardiac death, which could not be explained (Burr et al. 2003).”
BackgroundInfluentialBlood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146 · cited 1×
“…long-chain n-3 PUFA found in oily fish and fish oils protects against CVD inWestern populations (Miettinen et al. 1982; Kromhout et al. 1985, 1995; Shekelle et al. 1985; Norell et al. 1986; Feskens et al. 1993; Siscovick et al. 1995; Daviglus et al. 1997; Albert et al. 1998, 2002; Hu et al. 2002).”
BackgroundDavies, M. J., Richardson, P. D., Woolf, N., Katz, D. R., & Mann, J. (1993) · Heart · doi:10.1136/hrt.69.5.377 · Cited by 1,127
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018 · cited 1×
“There is epidemiological evidence that consumption of fish or long-chain n-3 PUFA found in oily fish and fish oils protects against CVD inWestern populations (Miettinen et al. 1982; Kromhout et al. 1985, 1995; Shekelle et al. 1985; Norell et al. 1986; Feskens et al. 1993; Siscovick et al. 1995; Daviglus et al. 1997; A…”
BackgroundFish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920 · cited 1×
“There is epidemiological evidence that consumption of fish or long-chain n-3 PUFA found in oily fish and fish oils protects against CVD inWestern populations (Miettinen et al. 1982; Kromhout et al. 1985, 1995; Shekelle et al. 1985; Norell et al. 1986; Feskens et al. 1993; Siscovick et al. 1995; Daviglus et al. 1997; A…”
BackgroundFish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836 · cited 8×
“A recent meta-analysis of randomized controlled trials, which compared dietary or non-dietary intake of n-3 PUFA with a control diet or placebo in patients with CVD, identified eleven trials fitting specific criteria relating to length of study, clinical outcomes etc., and concluded that n-3 PUFA reduce total mortalit…”
BackgroundInfluentialPolyunsaturated fatty acids, inflammation, and immunity
Calder, P. C. (2001) · Lipids · doi:10.1007/s11745-001-0812-7 · Cited by 784
Thies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739
Self-citationTan, N.-S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5114-5127.2002 · Cited by 499
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409 · cited 1×
“2002), although one study demonstrated a higher risk of cardiac death, which could not be explained (Burr et al. 2003).”
BackgroundLigand Selectivity of the Peroxisome Proliferator-Activated Receptor α
Lin, Q., Ruuska, S. E., Shaw, N. S., Dong, D., & Noy, N. (1999) · Biochemistry · doi:10.1021/bi9816094 · Cited by 263 · cited 1×
“…to be no distinction between the n-3 PUFA and the n-6 PUFA in their binding affinity and/ or activating capacity, and no relationship with chain length or number of double bonds (Forman et al. 1997; Kliewer et al. 1997; Krey et al. 1997; Lin et al. 1999; Wolfrum et al. 2001; Xu et al. 2001).”
BackgroundThies, F., Nebe-von-Caron, G., Powell, J. R., Yaqoob, P., Newsholme, E. A., & Calder, P. C. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.7.1918 · Cited by 232
Endres, S., Meydani, S. N., Ghorbani, R., Schindler, R., & Dinarello, C. A. (1993) · Journal of Leukocyte Biology · doi:10.1002/jlb.54.6.599 · Cited by 228
Liang, X., Nazarian, A., Erdjument-Bromage, H., Bornmann, W., Tempst, P., & Resh, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104018200 · Cited by 227 · cited 2×
“This process is thought to be possible because palmitoyl acyltransferase is a relatively promiscuous enzyme that is able to form covalent attachments between a wide range of fatty acids and proteins (Webb et al. 2000; Liang et al. 2001).”
BackgroundJohansen, O., Seljeflot, I., Høstmark, A. T., & Arnesen, H. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1681 · Cited by 169 · cited 3×
“Several studies have shown no effect on levels of soluble VCAM-1, while one study reported an increase (Johansen et al. 1999) and one study reported that supplementation with a moderate dose of fish oil (1.”
BackgroundPro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year
BLOK, W. L., DESLYPERE, J. ‐., DEMACKER, P. N. M., VAN DER VEN‐JONGEKRIJG, J., HECTORS, M. P. C., VAN DER MEER, J. W. M., & KATAN, M. B. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2240775.x · Cited by 129 · cited 1×
“However, many studies report no effect of fish oil on the production of inflammatory cytokines ex vivo (Molvig et al. 1991; Cooper et al. 1993; Cannon et al. 1995; Schmidt et al. 1996; Blok et al. 1997; Yaqoob et al. 2000).”
Background
Cited by
Fish Oil Replacement and Alternative Lipid Sources in Aquaculture Feeds
(2010) · CRC Press eBooks · doi:10.1201/9781439808634 · Cited by 505
The relationship between the fatty acid composition of immune cells and their function
Calder, P. C. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.016 · Cited by 499
Immune modulation by parenteral lipid emulsions
Wanten, G. J., & Calder, P. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1171 · Cited by 416
n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
Calder, P. C. (2013) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113001031 · Cited by 364
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.229 · Cited by 340
“…in postsurgical patients who receive enterally-delivered n-3 PUFAs vs. those who do not; although the salutary effects cannot be ascribed solely to the n-3 PUFAs because the supplements typically included other nutrients, the overall advantage is clear (Heyland et al., 2001; Yaqoob, 2004).”
Background
Metadata
- Authors
- Yaqoob, P.
- Venue
- Proceedings of the Nutrition Society
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-02
- Volume
- 63
- Issue
- 1
- Pages
- 89-105
- ISSN
- 0029-6651 (ISSN-L)
- 1475-2719
- OpenAlex
- W2164071126
- Cited by
- 139
- References
- 30
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.